Literature DB >> 3319422

Cell envelope of Candida albicans.

M G Shepherd1.   

Abstract

In this review, the cell envelope of the human pathogenic yeast Candida albicans includes the plasma membrane and the mannoproteins, enzymes, beta-glucans, and chitin of the wall. The organization of the wall is complex and ultrastructural studies show distinct "layers". Mannoprotein is distributed throughout the wall but is concentrated on the exterior surface and adjacent to the plasma membrane. The mannoproteins contain the antigenic determinants of the yeast cells. The major structural components of the wall are beta-1,3- and beta 1,6-glucans, and these two linkages are present in almost equal amounts. Chitin is concentrated at the bud scar, but small amounts are located over the entire wall where it appears to be linked to beta-1,6-glucan. Chemical bonding both within and between wall components confers rigidity on the wall and restricts movement of molecules into and out of the cell. Soluble enzymes are retained within the wall matrix, but a number of enzymes and proteins are excreted. The plasma membrane of C. albicans is similar to that isolated from other fungi and contains the proton pump ATPase and enzymes involved in biosynthesis of the wall such as chitin synthase and beta-1,3-glucan synthase.

Entities:  

Mesh:

Year:  1987        PMID: 3319422     DOI: 10.3109/10408418709104445

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  32 in total

1.  Sensitive assay for antifungal activity of glucan synthase inhibitors that uses germ tube formation in Candida albicans as an end point.

Authors:  Timothy G Brayman; John W Wilks
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 2.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

Review 3.  Midkine in host defence.

Authors:  A Gela; S Jovic; S L Nordin; A Egesten
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  Characterization of Aspergillus nidulans mutants deficient in cell wall chitin or glucan.

Authors:  P T Borgia; C L Dodge
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

Review 5.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

Review 6.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  CYP56 (Dit2p) in Candida albicans: characterization and investigation of its role in growth and antifungal drug susceptibility.

Authors:  N R Melo; G P Moran; A G S Warrilow; E Dudley; S N Smith; D J Sullivan; D C Lamb; D E Kelly; D C Coleman; S L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

8.  Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans.

Authors:  K C Hazen; B W Hazen
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species.

Authors:  E Pinto; K Hrimpeng; G Lopes; S Vaz; M J Gonçalves; C Cavaleiro; L Salgueiro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

10.  Antifungals: need to search for a new molecular target.

Authors:  A T Sangamwar; U D Deshpande; S S Pekamwar
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.